Anti-HIV-1 activity in vitro of ceftazidime degradation products

Antiviral Chemistry and Chemotherapy

Volumn 12, Issue 2, 2001, Pages 109-118

  Hobi, R ^a   Hubscher U ^a   Neftel, K ^a   Alteri, E ^a   Poncioni, B ^a   Walker, M R ^a   Woods Cook, K ^a   Schneider, P ^a   Lazdins, J K ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Ceftazidime; Cell fusion; Cephalosporins; HIV 1; Reverse transcriptase; RNase H

Indexed keywords

CD4 ANTIGEN; CEFTAZIDIME; GLYCOPROTEIN GP 120; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE;

ANTIVIRAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CELL FUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0034875029     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020101200204     Document Type: Article

References (31)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. CGP 53 437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity
3. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
4. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
5. Inhibition of HSV-1 and vaccinia virus replication by cephalosporin derivatives
6. Simian immunodeficiency virus from African green monkeys
7. Betalactam antibiotics interfere with eukaryotic DNA-replication by inhibiting DNA polymerase alpha
8. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes
9. Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbant assay
10. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives
11. HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H
12. Evidence of neutralizing antibodies against conformational epitopes of HIV-1 gp120
13. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay
14. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4
15. The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages
16. In vitro effect of transforming growth factor-β on progression of HIV-1 infection in primary mononuclear phagocytes
17. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
18. Simple, rapid quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
19. Quantitative infectivity assay for HIV-1 and -2
20. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
21. T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III
22. Complete nucleotide sequence of the AIDS virus, HTLV-III-
23. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2)
24. Evaluation of a soluble Tetrazolium/Formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
25. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
26. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription an integration in freshly isolated peripheral blood monozytes
27. Stability and degradation pattern of cefpirome (HR 810) in aqueous solution
28. Establishment and characterization of a human hystiocytic lymphoma cell line (U-937)
29. Biochemical and functional comparison of DNA polymerases α, δ and ε from calf thymus
30. CD-4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
31. Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1